How Direct-To-Consumer Television Advertising For Osteoarthritis Drugs Affects Physicians’ Prescribing Behavior

Bradford, W. David; Kleit, Andrew N.; Nietert, Paul J.; Steyer, Terrence E.; McIlwain, Thomas F.; Ornstein, Steven M.

doi:10.1377/hlthaff.25.5.1371

Cited by 67 publications

(53 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…5 A nationally representative survey in 2003 indicated that one-third of American adults had discussed a DTCA medication with their physician, and that 1 in 10 had received a prescription in response to their inquiry. 2 Proponents of DTCA suggest it can inform consumers of new therapies, [6][7][8] motivate them to seek care, 8 give them more autonomy in weighing Bennett Parnes, MD 1,2 Peter C. Smith, MD 1,4 Christine Gilroy, MD 5 Javan Quintela, BS 6,7,9 and lower drug costs by increasing competition. 6 Critics argue that DTCA provides incomplete and biased information, 10,11 leads to inappropriate prescribing, 12 increases costs as a result of the added costs of advertising, and consumes time in the physician-patient encounter.…”

mentioning

confidence: 99%

Lack of Impact of Direct-to-Consumer Advertising on the Physician-Patient Encounter in Primary Care: A SNOCAP Report

Parnes

Smith²,

Gilroy³

et al. 2009

The Annals of Family Medicine

View full text Add to dashboard Cite

PURPOSE Direct-to-consumer advertising (DTCA) has increased tremendously during the past decade. Recent changes in the DTCA environment may have affected its impact on clinical encounters. Our objective was to determine the rate of patient medication inquiries and their infl uence on clinical encounters in primary care. METHODSOur methods consisted of a cross-sectional survey in the State Networks of Colorado Ambulatory Practices and Partners, a collaboration of 3 practice-based research networks. Clinicians completed a short patient encounter form after consecutive patient encounter for one-half or 1 full day. The main outcomes were the rate of inquiries, independent predictors of inquiries, and overall impact on clinical encounters. RESULTSOne hundred sixty-eight clinicians in 22 practices completed forms after 1,647 patient encounters. In 58 encounters (3.5%), the patient inquired about a specifi c new prescription medication. Community health center patients made fewer inquiries than private practice patients (1.7% vs 7.2%, P <.001). Predictors of inquiries included taking 3 or more chronic medications and the clinician being female. Most clinicians reported the requested medication was not their fi rst choice for treatment (62%), but it was prescribed in 53% of the cases. Physicians interpreted the overall impact on the visit as positive in 24% of visits, neutral in 66%, and negative in 10%.CONCLUSIONS Patient requests for prescription medication were uncommon overall, and even more so among patients in lower income groups. These requests were rarely perceived by clinicians as having a negative impact on the encounter. Future mixed methods studies should explore specifi c socioeconomic groups and reasons for clinicians' willingness to prescribe these medications.

show abstract

mentioning

confidence: 99%

Lack of Impact of Direct-to-Consumer Advertising on the Physician-Patient Encounter in Primary Care: A SNOCAP Report

Parnes

Smith²,

Gilroy³

et al. 2009

The Annals of Family Medicine

View full text Add to dashboard Cite

show abstract

“…Although there is considerable variation in the results from prior studies based on differences in analytic approach and definitions of exposures and outcomes, the preponderance of evidence suggests that DTCA is associated with increases in consumer demand (17), physician diagnoses (9), the number of prescriptions (3,(8)(9)(10), prescription sales (10), therapeutic class size (18), and physician visits (19,20). Despite the insights from these prior studies, most examined DTCA exposure based on national expenditures, and many examined a single aggregated outcome, such as prescription volume alone.…”

Section: Discussionmentioning

confidence: 99%

Effect of Direct-to-Consumer Advertising on Asthma Medication Sales and Healthcare Use

Daubresse

Hutfless

Kim³

et al. 2015

Am J Respir Crit Care Med

View full text Add to dashboard Cite

Rationale: The United States is one of only two countries that permit direct-to-consumer advertising (DTCA) of prescription drugs, and many questions remain regarding its effects.Objectives: To quantify the association between asthma-related DTCA, pharmacy sales, and healthcare use.Methods: This was an ecological study from 2005 through 2009 using linked data from Nielsen (DTCA television ratings), the IMS Health National Prescription Audit (pharmacy sales), and the MarketScan Commercial Claims data (healthcare use) for 75 designated market areas in the United States. We used multilevel Poisson regression to model the relationship between DTCA and rates of prescriptions and use within and across designated market areas. Main outcome measures include (1) volume of total, new, and refilled prescriptions for advertised products based on pharmacy sales; (2) prescription claims for asthma medications; and asthma-related (3) emergency department use, (4) hospitalizations, and (5) outpatient encounters among the commercially insured.Measurements and Main Results: Four Food and Drug Administration-approved asthma medicines were advertised during the period examined: (1) fluticasone/salmeterol (Advair), (2) mometasone furoate (Asmanex), (3) montelukast (Singulair), and (4) budesonide/ formoterol (Symbicort). After adjustment, each additional televised advertisement was associated with 2% (incident rate ratio, 1.02; 95% confidence interval, 1.01-1.03) higher pharmacy sales rate from 2005 through 2009, although this effect varied across the three consistently advertised therapies examined. Among the commercially insured, DTCA was positively and significantly associated with emergency room visits related to asthma (incident rate ratio, 1.02; 95% confidence interval, 1.01-1.04), but there was no relationship with hospitalizations or outpatient encounters.Conclusions: Among this population, DTCA was associated with higher prescription sales and asthma-related emergency department use.

show abstract

“…For complete information, other ads in magazines or newspapers should be combined with broadcast ads. Moreover, one third of ads provided beneficial information, e.g., prevalence, understanding of misconception, risk factors and supportive treatment (appropriate lifestyle) and also increased discussion between users and their physicians which led to patients reeducation [17].…”

Section: Direct-to-consumer Promotion 1a Market Size and Sharementioning

confidence: 99%

Analysis of Scientific Researches in Pharmaceutical Promotion Globally: Towards Internationally Developing Practically-Oriented Guidelines for Pharmaceutical Companies

Bahlol¹,

Лагуткина²

2016

Bûll. sib. med.

View full text Add to dashboard Cite

Purpose. Pharmaceutical industry is transnational and globally important. Many pharmaceutical companies operate their business in multinational and international forms in different countries. Diverse researches from different countries indicated and confirmed marketing promotion importance in pharmaceutical field. Therefore, marketing promotion and its effects are a very important issue that should be globally investigated in real life and evidence context. We oriented our research according to these scientific and practical values.Methodology. We reviewed pharmaceutical marketing promotion researches from more than 25 different countries, e.g., USA, Canada, Italy, France, Russia, India, Egypt and Syria where we employed our knowledge of three widely spread languages, i.e., English, Russian and Arabic. Such language variation supports us with large and variable amount of scientific knowledge, deep understanding and ability of analysis. Some studies investigated average response to pharmaceutical marketing promotion and few studies took into consideration heterogeneity in their effects with respect to advertising medium or drug characteristics.Originality. We investigated empirical evidences of pharmaceutical marketing promotion that can be directed to either consumer or healthcare professionals.Findings. We extracted, gathered and associated information of pharmaceutical promotion globally which oriented us to several evidence and practical facts with regard to employing promotion tools in different definite situations pertinent to main directions; their welfare and health enhancing effects and adverse effects. Practical ImplicationsConsequently, we developed practically-oriented guidelines for companies concerning pharmaceutical promotion globally ate the end of this paper.

show abstract

How Direct-To-Consumer Television Advertising For Osteoarthritis Drugs Affects Physicians’ Prescribing Behavior

Cited by 67 publications

References 10 publications

Lack of Impact of Direct-to-Consumer Advertising on the Physician-Patient Encounter in Primary Care: A SNOCAP Report

Lack of Impact of Direct-to-Consumer Advertising on the Physician-Patient Encounter in Primary Care: A SNOCAP Report

Effect of Direct-to-Consumer Advertising on Asthma Medication Sales and Healthcare Use

Analysis of Scientific Researches in Pharmaceutical Promotion Globally: Towards Internationally Developing Practically-Oriented Guidelines for Pharmaceutical Companies

Contact Info

Product

Resources

About